MAT2B and neoplasm: In conclusion, our results demonstrate, for the first time, that the tumor suppressor miR-203 targets the 3’-UTRs of MAT2A and MAT2B and inhibits their expression, and show that miR-203 expression is genetically regulated and strongly contributes to determine patients’ outcome.